Gene-editing May Lower Risk of Heart Disease
February 8, 2017| |
A group of researchers in pharmaceutical firm AstaZeneca provided evidence that gene-editing could lessen the risk for heart disease. According to Lorenz Mayr, who leads the research on DNA editing technique, some people have a natural mutation that makes them have very low cholesterol levels. AstraZeneca developed a one-off injection that copies the effect of the mutation. When the injection was tested in mice, a significant decrease in cholesterol levels was observed. The researchers are still conducting more tests to make sure that the procedure will be safe for humans. He projects that if the study continues to provide positive results, human trials might happen in ten years' time. This treatment could be a good alternative to statins, which has negative side effects to some patients.
Read the original article in New Scientist.
| |
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
News from Around the World
- Scientists Make Genetic Recipe for Tastier Tomatoes
- Kenyan Farmers Urge the Gov't to Release WEMA Bt Maize Amid Ravaging Drought
- Scientists Find Diversity Blueprint to Help Maize Adapt to Changing Climates
- Geneticists Develop New Wheat Streak Mosaic Virus Resistance Genetic Markers
- Researchers Sequence Pitcher Plant Genome to Elucidate Plant Carnivory
- Indonesian Farmers are Ready to Adopt Biotech Corn
- Research on Mosses Provides Better Understanding of Plant Cell Biology
- Italian Scientists Search for Genes Involved in Carotenoid Synthesis in Wheat
- Rothamsted Research Granted Permission by Defra to Conduct GM Wheat Field Trials
-
Research Highlights
- Plant Ferredoxin-like Protein Expression Improves Photosynthesis in Rice
- Researchers Identify Candidate Gene for Compact Plant Architecture in Cucumber
-
Beyond Crop Biotech
- Tuberculosis Resistant Cows Produced Using CRISPR-Cas9n
- Gene-editing May Lower Risk of Heart Disease
-
Plant
- Researchers Develop MISSA 2.0 for Assembly of Orthogonal CRISPR/Cas Systems
- Development of Gene-Specific Rice Mutants via AvrXa23-based TALENs
-
Read the latest: - Biotech Updates (March 19, 2025)
- Gene Editing Supplement (March 12, 2025)
- Gene Drive Supplement (February 22, 2023)
-
Subscribe to BU: - Share
- Tweet